Search - tctmd.com

Displaying 801 - 820 of 911

Sort: Relevancy | Date

Presentation

Health-Related QOL After Transcatheter or Surgical Aortic Valve Replacement in High-Risk Pts with Severe Stenosis

Presenter: M. R. Reynolds

July 18, 2012

News Industry News

Edwards Intuity Valve System Cleared to Begin U.S. Trial

July 02, 2012

News Daily News

Subclavian CoreValve Implantation Found Safe as Alternative to Femoral Access

June 21, 2012

News Daily News

Permanent Pacemaker After TAVR Does Not Worsen Hard Outcomes

Caitlin E. Cox

June 21, 2012

News Daily News

FDA Panel Vote on TAVR Expansion Buoys Advocates

June 19, 2012

News Daily News

TAVR Achieves Positive Short-term Outcomes in Bicuspid Valves

Jason Kahn

June 18, 2012

News Industry News

FDA Panel Recommends Approval of Edwards Transcatheter Valve for High-Risk Patients

June 13, 2012

News Conference News EuroPCR 2012

TAVR Studies Tease Out Influences on Clinical Outcome

Caitlin E. Cox

May 18, 2012

News Conference News EuroPCR 2012

Global Valve-in-Valve Registry: Procedure Technically Challenging, but Highly Feasible

Caitlin E. Cox

May 16, 2012

News Industry News

Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial

May 15, 2012

News Daily News

Local Anesthesia Feasible, Safe in Transfemoral TAVR

May 11, 2012

News Daily News

La Anestesia Local es Viable y Segura en la TAVR Transfemoral

May 11, 2012

News Daily News

CMS Agrees to Cover TAVR for FDA-Approved Use

Caitlin E. Cox

May 07, 2012

News Daily News

French Registry Provides Window into Real-World TAVR Use

Caitlin E. Cox

May 03, 2012

News Daily News

TAVR Suitable Even in Patients with Impaired LVEF

Caitlin E. Cox

April 19, 2012

News Industry News

FDA Panel Scheduled to Review Edwards SAPIEN Valve for High-Risk Patients on June 13

April 09, 2012

News Conference News ACC 2012

Study Looks at Long-term Mortality Predictors in TAVR Patients

Jason Kahn

March 27, 2012

News Conference News ACC 2012

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

March 26, 2012

Presentation ACC 2012

Late (≥ 2 year) Clinical and Echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-Risk Cohort of The PARTNER Trial

Presenter: Susheel K. Kodali

March 26, 2012

News Conference News ACC 2012

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

March 24, 2012

Advertisement

Health-Related QOL After Transcatheter or Surgical Aortic Valve Replacement in High-Risk Pts with Severe Stenosis

Edwards Intuity Valve System Cleared to Begin U.S. Trial

Subclavian CoreValve Implantation Found Safe as Alternative to Femoral Access

Permanent Pacemaker After TAVR Does Not Worsen Hard Outcomes

FDA Panel Vote on TAVR Expansion Buoys Advocates

TAVR Achieves Positive Short-term Outcomes in Bicuspid Valves

FDA Panel Recommends Approval of Edwards Transcatheter Valve for High-Risk Patients

TAVR Studies Tease Out Influences on Clinical Outcome

Global Valve-in-Valve Registry: Procedure Technically Challenging, but Highly Feasible

Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial

Local Anesthesia Feasible, Safe in Transfemoral TAVR

La Anestesia Local es Viable y Segura en la TAVR Transfemoral

CMS Agrees to Cover TAVR for FDA-Approved Use

French Registry Provides Window into Real-World TAVR Use

TAVR Suitable Even in Patients with Impaired LVEF

FDA Panel Scheduled to Review Edwards SAPIEN Valve for High-Risk Patients on June 13

Study Looks at Long-term Mortality Predictors in TAVR Patients

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

Late (≥ 2 year) Clinical and Echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-Risk Cohort of The PARTNER Trial

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content